Darifenacin
生产企业:Novartis pharmaceuticals corp
Darifenacin is an M3 muscarinic receptor blocker used to treat urinary incontinence.
Darifenacin is an M3 muscarinic receptor blocker used to treat urinary incontinence.
Darifenacin selectively antagonizes the muscarinic M3 receptor. M3 receptors are involved in contraction of human bladder and gastrointestinal smooth muscle, saliva production, and iris sphincter function.
For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.
共 1 项相关疾病
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。